✦ LIBER ✦

Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers

✍ Scribed by David M. Hyman; Qin Zhou; Angela G. Arnold; Rachel N. Grisham; Alexia Iasonos; Noah D. Kauff; David Spriggs

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Third-line chemotherapy in platinum- and

✍ S. Tangjitgamol; H. T. See; S. Manusirivithaya; C. F. Levenback; D. M. Gershenso 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Phase II evaluation of topotecan and nav

✍ Thomas J. Herzog; Matthew A. Powell; Janet S. Rader; Randall K. Gibb; Lynne Lipp 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Phase 2 trial of prolonged administratio

✍ Maurie Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Gertrude Peters 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Topotecan in heavily pretreated patients

✍ B. PIURA; A. RABINOVICH 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

A phase II trial of weekly docetaxel in

✍ Anna Berkenblit; Michael V. Seiden; Ursula A. Matulonis; Richard T. Penson; Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Combined weekly topotecan and biweekly b

✍ Kathryn F. McGonigle; Howard G. Muntz; Jacqueline Vuky; Pamela J. Paley; Dan S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB